Clinical trial
Evaluation of the Safety and Efficacy of the NuEra Tight VRF for the Treatment of Vaginal and Vulvar Tissue Laxity
NCT04511260 is registered in ClinicalTrials.gov with Lumenis Be Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Efficacy of the NuEra Tight VRF for the Treatment of Vaginal and Vulvar Tissue Laxity
- Lead sponsor
- Lumenis Be Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 16, 2020
- Completion date
- June 20, 2021
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vagina atrophy